Newsroom

Recent news, statements, and resources

Newsroom

Recent news, statements, and resources

Welcome to The Leukemia & Lymphoma Society Newsroom

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

News_Picture

FDA Approves New Targeted Treatment for CLL/SLL

February 6, 2023

Team In Training

Sharing Decades of a Dedicated Vision to End Cancer

February 1, 2023

FDA-Approval-Lymphoma

FDA Approves New Type of BTK Inhibitor to Treat Mantle Cell Lymphoma

January 27, 2023

researcher

LLS Mourns the Passing of C. David Allis, PhD

January 11, 2023

The US Capitol

Insured Cancer Patients Continue to Face Barriers To Medically Necessary Treatment, New Report Warns

January 9, 2023

FDA-Approval-Lymphoma

FDA Approves the First-in-Class Bispecific Antibody for Treatment of Follicular Lymphoma

December 23, 2022

From left to right: Dr. Louis DeGennaro, LLS President & CEO; Dr. Stephen Ansell, LLS Excellence in Scientific Service recipient; Dr. Gwen Nichols, LLS Chief Medical Officer; Dr. Lee Greenberger, LLS Chief Scientific Officer

The Leukemia & Lymphoma Society Honors Six Outstanding Blood Cancer Scientists with 2022 Achievement Awards

December 23, 2022

FDA Approved Misc

FDA Approves New Targeted Treatment Option for Certain Forms of Acute Myeloid Leukemia in Adults

December 2, 2022

Researcher

The Leukemia & Lymphoma Society’s Presence at ASH Showcases Progress to Advance Cures and Care for Blood Cancer Patients

November 28, 2022

Media Requests

For all media-related inquiries and interview requests please email mediarelations@lls.org. An LLS representative will respond as soon as possible.